Quantitative, multiplexed analysis of multiple biomarkers from a single biopsy sample

A patented nanobead technology combined with AI-powered analysis and an advanced optical system to deliver more precise and reliable cancer diagnostics results.
vega laboratories

Streamline Operations, Reduce Costs and Improve Diagnostic Throughput

Vega analysis

Vega BioImaging provides cutting-edge diagnostic solutions tailored
for clinical and research laboratories. Our solution include:

  • Multiplexed Biomarker Detection utilizing our proprietary nanobead technology.

  • Advanced Image Analysis thanks to our advanced optical imaging system, combined with AI-powered data interpretation.

  • Customizable Diagnostic Kits offering enhanced sensitivity and stability while streamlining the processing of cancer samples with minimal reagent use.

  • Streamlined Workflow Integration thanks to its easy integration into existing lab infrastructure. No need for extensive retraining or system overhauls.
Contact us

Solution Components
for Faster and Reliable Cancer Diagnostics

Vega
01

Nanobead Technology

Vega BioImaging’s patented nanobeads enable labs to perform highly sensitive and quantitative multiplexing. This technology allows for the simultaneous detection of multiple biomarkers in a single biopsy sample, enhancing diagnostic precision and improving the ability to assess complex cancer profiles. The nanobeads are stable, easy to handle, and ensure reproducible results, reducing diagnostic errors and variability between tests.
Vega
02

Optical system

Our advanced optical system provides high-resolution imaging, allowing labs to visualize biopsy samples with greater clarity and precision. The system is designed for easy integration into existing workflows, providing consistent, high-quality images that improve diagnostic accuracy. Unlike traditional fluorescence methods, Vega’s optical system avoids signal degradation, ensuring reliable long-term data.
Vega
03

AI-Powered Analysis

Vega BioImaging’s AI algorithms automate the analysis of complex biomarker data, providing labs with fast, accurate, and actionable insights. The AI system enhances diagnostic consistency, reduces the potential for human error, and streamlines data interpretation, enabling labs to deliver faster, more reliable results to clinicians and researchers.

A Convenient and Scalable
Solution to Add Accuracy
and Precision

Increased Diagnostic Accuracy

Vega’s nanobead technology provides quantitative, multiplexed biomarker detection, significantly improving the precision and reliability of cancer diagnostics, reducing errors, and enhancing reproducibility.

Faster Turnaround Times

Our AI-powered analysis and advanced optical system streamline sample processing and data interpretation, enabling labs to deliver results more quickly and efficiently, reducing workflow bottlenecks.

Enhanced Operational Efficiency

Vega’s solution integrates easily into existing lab infrastructure, reducing the need for multiple tests and manual interventions, and allowing labs to handle higher volumes of samples with less time and resource investment.

Cost Savings

By minimizing the use of reagents, reducing the need for repeat testing, and increasing diagnostic accuracy, labs can lower their operational costs while improving service quality.

Scalability and Flexibility

The platform is adaptable for both clinical and research settings, allowing labs to scale up operations and explore new biomarkers, making it suitable for a wide range of diagnostic needs and research applications.
Vega

Partner with us

Why Vega Bioimaging
Partner with Vega BioImaging to revolutionize your drug development process. Discover how our cutting-edge diagnostics can enhance precision, reduce costs, and accelerate time-to-market.
Get Started Today